IMDELLTRA
Live / Registered — Registered (as of 01 Oct 2024)
What this means for you
Registered since 01 Oct 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97526782
- Registration number
- 7524164
- Mark type
- Stylized text
- Filed
- 29 Jul 2022
- Published for opposition
- 16 May 2023
- Registered
- 01 Oct 2024
- Attorney of record
- Elsa D. Lemoine
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations used for the treatment of cancer; pharmaceutical preparations used for the treatment of lung, prostate and respiratory disorders
Owner
- Amgen Inc., Thousand Oaks, CA, US
- Amgen Inc., Thousand Oaks, CA, US
- Amgen Inc., Thousand Oaks, CA, US
Prosecution history
- 25 Feb 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 25 Feb 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 25 Feb 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 01 Oct 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 01 Oct 2024 — REGISTERED-PRINCIPAL REGISTER
- 27 Aug 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 27 Aug 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 02 Jul 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 23 May 2024 — USE AMENDMENT FILED
- 01 Jul 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 23 May 2024 — TEAS STATEMENT OF USE RECEIVED
- 06 Jan 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 04 Jan 2024 — SOU EXTENSION 1 GRANTED
- 04 Jan 2024 — SOU EXTENSION 1 FILED
- 04 Jan 2024 — SOU TEAS EXTENSION RECEIVED